eMed
PrivateLast Round
Series A
Mar 26, 2026
Est. Valuation
$2B
Total Funding Raised
$200M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
eMed is a healthtech company that provides a digital health platform offering telehealth services, at-home diagnostics, and clinically managed GLP-1 weight management programs for employers and individuals.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Medical Devices, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
eMed Comparables
Compare eMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Everly Health | 83% | |
| LetsGetChecked | 80% | |
| Fuze Health | 74% |
eMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 26, 2026 |
eMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Knighthead Capital Management | Series A |
| Paragon Biosciences | Series A |
| 8VC | Series A |
| Valor Equity Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 129% MoM, reaching 299.1K.
- Aug 1, 2026
Open roles increased to 158, 56% of headcount.
eMed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about eMed's valuation, stock price, and market status.
Is eMed a public or private company?
eMed is a private company.
What is the current stock price of eMed?
eMed is a private company with no public stock price. No recent secondary market data is available.
How much is eMed worth (valuation)?
eMed's valuation is estimated at $2.0B based on funding round data.
Can I buy eMed stock?
eMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was eMed's last funding round?
eMed's most recent funding round was Series A on March 26, 2026.
Who are the main investors in eMed?
Key investors in eMed include Knighthead Capital Management, Paragon Biosciences, 8VC, Valor Equity Partners.
Will eMed IPO soon?
No public IPO plans have been announced for eMed.
How can I track eMed secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor eMed's secondary market activity and sign up for updates.